Literature DB >> 26943952

Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses.

Makoto Kubo1, Ryuichi Nagashima2, Etsuro Ohta3, Tatsunori Maekawa4, Yumiko Isobe2, Mitsue Kurihara2, Koji Eshima5, Kazuya Iwabuchi5, Toshikuni Sasaoka6, Sadahiro Azuma7, Heather L Melrose8, Matthew J Farrer9, Fumiya Obata3.   

Abstract

LRRK2 is the causal molecule of autosomal dominant familial Parkinson's disease. B2 cells express a much higher LRRK2 mRNA level than B1 cells. To reveal the function of LRRK2 in B cells, we analyzed B cell functions in LRRK2-knockout (LRRK2(-/-)) mice. LRRK2(-/-) mice had significantly higher counts of peritoneal B1 cells than wild-type mice. After BCR stimulation, phosphor-Erk1/2 of splenic B2 cells was enhanced to a higher degree in LRRK2(-/-) mice. LRRK2(-/-) mice had a significantly higher serum IgA level, and TNP-Ficoll immunization increased the titer of serum anti-TNP IgM antibody. LRRK2 may play important roles in B cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  B cell receptor signaling; B1 cell; B2 cell; IgA; Leucine-rich repeat kinase 2; TI antigen

Mesh:

Substances:

Year:  2016        PMID: 26943952     DOI: 10.1016/j.jneuroim.2016.01.005

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  LRRK2: An Emerging New Molecule in the Enteric Neuronal System That Quantitatively Regulates Neuronal Peptides and IgA in the Gut.

Authors:  Tatsunori Maekawa; Hitomi Shimayama; Hiromichi Tsushima; Fumitaka Kawakami; Rei Kawashima; Makoto Kubo; Takafumi Ichikawa
Journal:  Dig Dis Sci       Date:  2017-02-06       Impact factor: 3.199

2.  LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.

Authors:  Ruiqing Yan; Zhihua Liu
Journal:  Protein Cell       Date:  2016-11-09       Impact factor: 14.870

3.  LRRK2 is involved in the pathogenesis of system lupus erythematosus through promoting pathogenic antibody production.

Authors:  Meiyu Zhang; Chengcheng Yao; Jun Cai; Shuai Liu; Xia-Nan Liu; Yingying Chen; Shujun Wang; Ping Ji; Meng Pan; Zizhen Kang; Ying Wang
Journal:  J Transl Med       Date:  2019-01-22       Impact factor: 5.531

4.  Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells.

Authors:  Makoto Kubo; Ryuichi Nagashima; Mitsue Kurihara; Fumitaka Kawakami; Tatsunori Maekawa; Koji Eshima; Etsuro Ohta; Hirotomo Kato; Fumiya Obata
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

Review 5.  B cells in autoimmune and neurodegenerative central nervous system diseases.

Authors:  Joseph J Sabatino; Anne-Katrin Pröbstel; Scott S Zamvil
Journal:  Nat Rev Neurosci       Date:  2019-11-11       Impact factor: 34.870

6.  A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human Lymphoblasts.

Authors:  Tianxia Li; Bo Ning; Lingbo Kong; Bingling Dai; Xiaofei He; Joseph M Thomas; Akira Sawa; Christopher A Ross; Wanli W Smith
Journal:  Cells       Date:  2021-02-23       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.